Mon, 14 Oct 2019 13:20:21: Marrying CRISPR with immuno-oncology to defeat remote tumors

Mon, 14 Oct 2019 12:48:55: BridgeBio scraps plan to buy Eidos after bids rebuffed

Mon, 14 Oct 2019 12:14:19: ReNeuron shares clinical data on stem cell vision loss therapy

Mon, 14 Oct 2019 10:19:31: CAR-T cells as 'bait' show promise in autoimmune diseases

Mon, 14 Oct 2019 09:12:52: Covance clinical development lead takes the reins at Pharm-Olam

Fri, 11 Oct 2019 15:45:38: Koalas shed light on DNA's ability to resist cancer-causing viruses

Fri, 11 Oct 2019 13:20:32: Pfizer posts detailed phase 3 data on its Dupixent rival

Fri, 11 Oct 2019 11:38:44: Aridis nabs pharma veteran as ex-CMO leaves for 'personal reasons' after drug flop

Fri, 11 Oct 2019 10:51:55: Gilead, Galapagos share 52-week update on filgotinib

Fri, 11 Oct 2019 10:21:56: Five Prime's new CEO wields ax, laying off 70 staffers

Thu, 10 Oct 2019 18:50:38: Chutes & Ladders—Gilead Sciences nabs ex-Genentech exec Parsey as next CMO

Thu, 10 Oct 2019 13:28:48: J&J offloads midphase pain program to Neumentum

Thu, 10 Oct 2019 12:41:35: Alexion bags option on Stealth's phase 3 rare disease drug

Thu, 10 Oct 2019 09:08:58: UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris

Thu, 10 Oct 2019 07:11:53: Parexel pens Datavant tech deal for trial workflows

Wed, 09 Oct 2019 15:25:53: How Viagra could boost a widely used blood cancer treatment

Wed, 09 Oct 2019 12:24:36: Novo taps bluebird bio for gene-editing tech

Wed, 09 Oct 2019 12:15:51: Bayer forms drug discovery pact with Japan's Riken Innovation

Wed, 09 Oct 2019 08:37:22: Greenwood to step down as CEO of BIO after 2020 election

Tue, 08 Oct 2019 12:51:54: Merck taps 4D pharma for bacterial vaccine R&D project

Tue, 08 Oct 2019 12:11:34: Chasing AbbVie, Gilead files for approval of filgotinib in Japan

Tue, 08 Oct 2019 07:42:43: Chinese infectious disease biotech Ascletis nabs Novartis exec as CSO

Mon, 07 Oct 2019 13:33:27: Early readout from small NGM study shows NASH drug hits liver fat, but shares fall

Mon, 07 Oct 2019 13:16:41: Amid C-suite shake-up, Gilead nabs Genentech exec as new CMO

Mon, 07 Oct 2019 12:49:25: Oxford spinout MiroBio bags £27M for autoimmune R&D